Literature DB >> 8815941

Evidence of apoptosis in arrhythmogenic right ventricular dysplasia.

Z Mallat1, A Tedgui, F Fontaliran, R Frank, M Durigon, G Fontaine.   

Abstract

BACKGROUND: Arrhythmogenic right ventricular dysplasia, a disorder that may lead to severe ventricular arrhythmias and sudden death, is characterized by the progressive replacement of myocardial cells by fat and fibrous tissue. We examined whether the loss of myocardial cells in this disease could result from cell death by apoptosis (programmed cell death).
METHODS: Specimens obtained at autopsy from the right ventricular myocardium of eight patients with arrhythmogenic right ventricular dysplasia and four age-matched normal subjects were analyzed. To identify individual cells undergoing apoptosis, we performed in situ end-labeling of fragmented DNA on paraffin sections using biotinylated deoxyuridine triphosphate and the enzyme terminal deoxynucleotidyl transferase. We also examined the level of expression of CPP-32, a cysteine protease required for apoptotic cell death in mammalian cells, using immunohistochemical techniques.
RESULTS: Apoptosis was detected in the right ventricular myocardium of six of the eight patients with arrhythmogenic right ventricular dysplasia and was absent in the controls. High levels of expression of CPP-32 were associated with positive in situ end-labeling of fragmented DNA.
CONCLUSIONS: These results indicate that apoptotic myocardial cell death occurs in arrhythmogenic right ventricular dysplasia and may contribute to the loss of myocardial cells in this disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8815941     DOI: 10.1056/NEJM199610173351604

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  79 in total

Review 1.  Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Mireia Alcalde; Oscar Campuzano; Georgia Sarquella-Brugada; Elena Arbelo; Catarina Allegue; Sara Partemi; Anna Iglesias; Antonio Oliva; Josep Brugada; Ramon Brugada
Journal:  Clin Res Cardiol       Date:  2014-11-15       Impact factor: 5.460

2.  Essential myosin light chain as a target for caspase-3 in failing myocardium.

Authors:  Alessandra Moretti; Hans-Jörg Weig; Thomas Ott; Melchior Seyfarth; Hans-Peter Holthoff; Diana Grewe; Angelika Gillitzer; Lorenz Bott-Flügel; Albert Schömig; Martin Ungerer; Karl-Ludwig Laugwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-19       Impact factor: 11.205

3.  The human heart: a self-renewing organ.

Authors:  Jan Kajstura; Toru Hosoda; Claudia Bearzi; Marcello Rota; Silvia Maestroni; Konrad Urbanek; Annarosa Leri; Piero Anversa
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

4.  Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy.

Authors:  Q Li; B Li; X Wang; A Leri; K P Jana; Y Liu; J Kajstura; R Baserga; P Anversa
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

5.  The locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14.

Authors:  D Li; F Ahmad; M J Gardner; D Weilbaecher; R Hill; A Karibe; O Gonzalez; T Tapscott; G P Sharratt; L L Bachinski; R Roberts
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

6.  Gene transfer of the pancaspase inhibitor P35 reduces myocardial infarct size and improves cardiac function.

Authors:  Lorenz Bott-Flügel; Hans-Jörg Weig; Martina Knödler; Christian Städele; Alessandra Moretti; Karl-Ludwig Laugwitz; Melchior Seyfarth
Journal:  J Mol Med (Berl)       Date:  2005-06-21       Impact factor: 4.599

7.  Enhanced expression of the ubiquitin-proteasome system in the myocardium from patients with dilated cardiomyopathy referred for left ventriculoplasty: an immunohistochemical study with special reference to oxidative stress.

Authors:  Koji Otsuka; Fumio Terasaki; Hiroaki Shimomura; Bin Tsukada; Taiko Horii; Tadashi Isomura; Hisayoshi Suma; Yuro Shibayama; Yasushi Kitaura
Journal:  Heart Vessels       Date:  2010-09-29       Impact factor: 2.037

Review 8.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare "disease of the desmosome" with multiple clinical presentations.

Authors:  Thomas Herren; Philipp A Gerber; Firat Duru
Journal:  Clin Res Cardiol       Date:  2009-02-09       Impact factor: 5.460

Review 9.  Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease.

Authors:  Ardan M Saguner; Corinna Brunckhorst; Firat Duru
Journal:  World J Cardiol       Date:  2014-04-26

Review 10.  Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Mark M Awad; Hugh Calkins; Daniel P Judge
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.